Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Triple sleep-promotion for delirium prevention in ICU patients

Official title: Effect of a Triple Sleep-promotion Protocol on Delirium Incidence in Intensive Care Units: A Multicenter Stratified Randomized Controlled Trial

Run by Çanakkale Onsekiz Mart University · NCT07801092 · Data updated 2026-11-12

In this randomized trial, adult ICU patients who don’t have delirium yet will be assigned to either a multicomponent sleep-promotion protocol or usual care to see if better sleep reduces new delirium.

More Delirium Confusional State trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorÇanakkale Onsekiz Mart University
Academic / other
Locations1 site (Çanakkale, Çanakkale)
StatusRecruiting
StartedAugust 15, 2026
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedSeptember 9, 2026
Trial IDNCT07801092 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older admitted to participating ICUs with at least 24 hours expected stay, without delirium at baseline, and able to communicate in Turkish.

Probably not a fit

Patients who already have delirium at baseline or cannot safely implement sleep-promoting measures may not benefit from the protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized controlled trial tests whether a multicomponent nighttime sleep-promotion protocol can lower the incidence of new-onset delirium in adult ICU patients. The protocol includes clustering nighttime nursing care, providing an eye mask and earplugs during protected sleep periods, and reducing avoidable nighttime light and noise when possible, while prioritizing patient safety. Participants will be followed for the duration of their ICU stay to track delirium occurrence, subjective sleep quality, and adherence to the intervention. The study is conducted in four ICUs in Türkiye and compares the intervention against standard ICU care.

Why it matters

Potential benefit: If successful, the protocol could reduce delirium risk in ICU patients by improving nighttime sleep without adding medications.

How similar studies have gone: Previous nonpharmacological sleep-promotion efforts in ICUs have shown mixed results; this study tests a structured, multicomponent approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Admitted to one of the participating intensive care units.
* Expected ICU stay of at least 24 hours.
* Richmond Agitation-Sedation Scale (RASS) score between -3 and +4 at baseline.
* Negative Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) assessment at baseline.
* Able to communicate in Turkish when communication is required for study assessments.
* Written informed consent provided by the patient or, when the patient is unable to provide consent because of their clinical condition, by a first-degree relative.

Exclusion Criteria:

* Positive CAM-ICU assessment at baseline.
* Dementia or a severe neurological disorder that may interfere with delirium assessment, including stroke or severe head trauma.
* Delirium related to alcohol or substance withdrawal.
* Visual or hearing impairment that prevents implementation of the sleep-promotion intervention.
* Ear infection or tympanic membrane perforation that precludes the use of earplugs.
* Terminal clinical condition.

Where it's running

  • Çanakkale Onsekiz Mart University, Faculty of Health Sciences
    Çanakkale, Çanakkale, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Naile Alankaya — Çanakkale Onsekiz Mart University, Faculty of Health Sciences
  • Study coordinator: Naile Alankaya, Assosiate Prof. PhD
  • Email: naile.alankaya@gmail.com
  • Phone: +905334256510

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.